SHPS-1 is an *120 kDa glycosylated receptor like protein that contains three immunoglobulin-like domains in its extracellular region as well as four potential tyrosine phosphorylation and SRC homology 2 (SH2) domain binding sites in its cytoplasmic region. Lysophosphatidic acid (LPA) stimulated the rapid tyrosine phosphorylation of SHPS-1 and its subsequent association with SHP-2, a protein tyrosine phosphatase containing SH2 domains in Rat-1 ®broblasts. LAP-induced tyrosine phosphorylation of SHPS-1 was inhibited by Clostridium botulinum C3 exoenzyme (which inactivates RHO) but not by pertussis toxin. The protein kinase C activator phorbol ester, 12-O-tetradecanoylphorbol 13-acetate (TPA) also stimulated tyrosine phosphorylation of SHPS-1; however, down-regulation of protein kinase C by prolonged exposure of cells to TPA did not aect LAP-induced tyrosine phosphorylation of SHPS-1. LPA-induced tyrosine phosphorylation of SHPS-1 was markedly reduced in either focal adhesion kinase (FAK)-de®cient mouse cells or CHO cells overexpressing the tyrosine kinase CSK. Overexpression of a catalytically inactivate SHP-2 markedly inhibited MAP kinase activation in response to low concentrations of LPA in CHO cells, whereas overexpression of a wild-type SHPS-1 did enhance this eect of LPA. Furthermore, MAP kinase activation in response to a low concentration of LPA was inhibited by botulinum C3 exoenzyme. These results indicate that LPA-induced tyrosine phosphorylation of SHPS-1 and its association with SHP-2 may be mediated by a RHO-dependent pathway that includes FAK and a SRC family kinase. Thus, in addition to its role in receptor tyrosine kinase-mediated MAP kinase activation, the formation of a complex between SHPS-1 and SHP-2 may, in part, play an important role in the activation of MAP kinase in response to low concentrations of LPA.
Introduction
SHP-2 is a non-transmembrane protein tyrosine phosphatase that contains two SRC homology 2 (SH2) domains (Adachi et al., 1996; Matozaki and Kasuga, 1996; Neel and Tonks, 1997) . SHP-2 binds directly to growth factor receptors, such as those of platelet-derived growth factor receptor and epidermal growth factor (EGF) receptor, and undergoes tyrosine phosphorylation in response to receptor stimulation by ligand Vogel et al., 1993; Matozaki and Kasuga, 1996; Neel and Tonks, 1997) . Furthermore, in response to insulin, SHP-2 binds via its SH2 domains to IRS-1, a major substrate for the insulin receptor tyrosine kinase (Sun et al., 1991) and is thereby activated (KuhneÂ et al., 1993; Matozaki et al., 1995; Pluskey et al., 1995) . The expression of a catalytically inactive SHP-2 inhibits insulin-induced activation of RAS and mitogen-activated protein (MAP) kinase (Noguchi et al., 1994; Milarski and Saltiel, 1994; Xiao et al., 1994; Yamauchi et al., 1995) as well as EGF-induced MAP kinase activation (Bennett et al., 1996) and thereby blocks DNA synthesis and cell proliferation. Moreover, microinjection of RNAs encoding catalytically inactive SHP-2 into Xenopus oocytes induces marked posterior truncation and inhibits ®broblast growth factor-and activin-mediated mesoderm induction (Tang et al., 1995) . Thus, SHP-2 may play a general role in intracellular signaling elicited by various growth factors and hormones, probably through activation of the RAS-MAP kinase pathway.
We have recently characterized a membrane glycoprotein, SHPS-1 (SHP substrate-1) Noguchi et al., 1996; Yamao et al., 1997) (also known as SIRP1 (Kharitonenkov et al., 1997) or BIT (Ohnishi et al., 1996) ), whose extracellular region contains three homologous immunoglobulin-like domains and multiple N-linked glycosylation sites. The cytoplasmic region of SHPS-1 contains four tyrosine residues followed by XX(L/V/I) sequences (Y408ADL, Y432ASI, Y449ADL and Y473ASV), which represent potential tyrosine phosphorylation sites. Insulin, EGF, serum and cell adhesion each rapidly stimulates tyrosine phosphorylation of SHPS-1 and its association with SHP-2 Kharitonenkov et al., 1997) . In vitro binding studies with a phosphotyrosyl peptide library have suggested that the SH2 domains of SHP-2 bind to phosphopeptides that contain the sequence motif pYXX(L/V/I) (Songyang et al., 1993; Fujioka et al., 1996) , where pY represents phosphorylated tyrosine. Thus, the SH2 domains of SHP-2 may bind to one or more phosphorylated tyrosine residues in the cytoplasmic domain of SHPS-1. The extent of tyrosine phosphorylation of SHPS-1 is greatly increased in cells that overexpress catalytically inactive SHP-2 (Cys 459 to Ser) Noguchi et al., 1996) . Thus, SHPS-1 may be a target for the phosphatase activity of SHP-2, although this form of a catalytically inactive SHP-2 is not a substrate trapping mutant (Flint et al., 1997) . SHPS-1 appears to be a docking protein, such as IRS-1, Gab-1 (Holgado-Madruga et al., 1996) and DOS (Herbst et al., 1996) , that recruits SHP-2 from the cytosol to a site near the plasma membrane in response to various growth factors or cell adhesion. The synthetic phosphotyrosyl peptide containing sequence surrounding Tyr 449 and Tyr 473 increases the phosphatase activity of SHP-2 in vitro, suggesting that the binding of SHP-2 to tyrosine-phosphorylated SHPS-1 may stimulate the PTPase activity of SHP-2 (Ohnishi et al., 1996) . After activation induced by binding to SHPS-1, SHP-2 may dephosphorylate and dissociate from SHPS-1, stimulating the RAS ± MAP kinase cascade through dephosphorylation of an unknown target protein.
Lysophosphatidic acid (LPA) induces a variety of biological responses including mitogenesis, smooth muscle contraction, platelet aggregation, and cell motility (Moolenaar, 1994) . These actions appear to be mediated by both pertussis toxin (PTX) sensitiveand PTX-insensitive G proteins; the former may stimulate RAS ± MAP kinase activation and inhibit adenylate cyclase, whereas the latter may induce polyphosphoinositide breakdown (van Corven et al., 1989; Hordijk et al., 1994; Moolenaar, 1994) . In addition, the small GTP-binding proteins RHO (Narumiya, 1993 ) is implicated in LPA-induced assembly of focal adhesions and the formation of actin stress ®bers (Ridley and Hall, 1992; Nobes and Hall, 1995) . LPA also stimulates tyrosine phosphorylation of several proteins, including focal adhesion kinase (FAK) and paxillin, in a RHO-dependent pathway (Hordijk et al., 1994; Rankin et al., 1994; Sueerlein and Rozengurt, 1994) .
Similar to the actions of insulin and EGF, we have shown that LPA also induces tyrosine phosphorylation of SHPS-1 and its association with SHP-2 in Rat-1 ®broblasts . However, the mechanism by which LPA induces tyrosine phosphorylation of SHPS-1 and the roles of SHP-2 and SHPS-1 in the biological actions of LPA remain unclear. We have now shown that LPA-induced tyrosine phosphorylation of SHPS-1 and its interaction with SHP-2 are inhibited by the treatment with Clostridium botulinum C3 exoenzyme.
Furthermore, LPA-induced tyrosine phosphorylation of SHPS-1 was markedly reduced in FAKde®cient cells or in cells overexpressing the tyrosine kinase CSK. Finally, we have also shown that the expression of a catalytically inactive SHP-2 inhibits LPA-induced MAP kinase activation, while that of SHPS-1 enhances this eect of LPA.
Results
Eects of botulinus C3 exoenzyme and PTX on LPA-induced tyrosine phosphorylation of SHPS-1 and its interaction with SHP-2
We have previously shown that SHPS-1 is tyrosinephosphorylated and is coimmunoprecipitated with antibodies to SHP-2 in lysates of LPA-stimulated Rat-1 cells . To investigate the eect of LPA on the interaction between SHPS-1 and SHP-2, we generated a monoclonal antibody (mAb) 2F34 that is able to immunoprecipitate rat SHPS-1. Serum-deprived Rat-1 cells were incubated with 1 mM LPA for various times, lysed, and subjected to immunoprecipitation with mAb 2F34. Immunoblot analysis of immunoprecipitation with antibodies to phosphotyrosine or to SHP-2 revealed that SHPS-1 is tyrosine-phosphorylated and associated with SHP-2 in even unstimulated cells (Figure 1 ), possibly because of the eect of cell adhesion . However, LPA induced a rapid increase in both the extent of tyrosine phosphorylation of SHPS-1 and the amount of SHP-2 associated with SHPS-1; these eects peaked at *5 min and thereafter declined (Figure 1a) . SHPS-1 has been suggested to be a substrate for the phosphatase activity of SHP-2 Noguchi et al., 1996; Kharitonenkov et al., 1997) ; thus, after binding to phosphorylated SHPS-1 in response to LPA, SHP-2 may catalyze SHPS-1 dephosphorylation. The eect of LPA on both tyrosine phosphorylation of SHPS-1 and its association with SHP-2 increased in a concentration-dependent manner, being maximal at 1 mM LPA (Figure 1b) .
We next examined the eects of PTX on LPAinduced tyrosine phosphorylation of SHPS-1, given that a PTX-sensitive G protein, presumably G i or G o , is thought to mediate certain actions of LPA, such as activation of MAP kinase (Hordijk et al., 1994; Moolenaar, 1994) . MAP kinase activation was determined by immunoblot analysis of cell lysates with antibodies speci®c for tyrosine-phosphorylated MAP kinase. Pretreatment of Rat-1 cells with PTX almost completely inhibited 1 mM LPA-induced MAP kinase activation, as previously described (Hordijk et al., 1994; Moolenaar, 1994; Dikic et al., 1996) , but it had no substantial eect on LPA-induced tyrosine phosphorylation of SHPS-1 or its association with SHP-2 (Figure 2a) . In contrast, pretreatment of Rat-1 cells with botulinus C3 exoenzyme almost totally inhibited LPA-induced tyrosine phosphorylation of SHPS and its association with SHP-2, without substantially aecting LPA-induced MAP kinase activation ( Figure  2b ), although C3 exoenzyme did inhibit MAP kinase activation in response to a low concentration of LPA (Figure 5b ). Botulinus C3 exoenzyme speci®cally inactivates RHO by catalyzing its ADP-ribosylation (Narumiya and Morii, 1993; Rankin et al., 1994; Kumagai et al., 1995) . LPA-induced formation of actin-stress ®bers and focal contacts is inhibited by microinjection of the C3 exoenzyme into cells, suggesting that RHO may mediate these eects of LPA (Ridley and Hall, 1992; Nobes and Hall, 1995) . Thus, these data suggest that LPA-induced tyrosine phosphorylation of SHPS-1 and its subsequent interaction with SHP-2 require RHO, but not a PTXsensitive G protein. LPA also induced tyrosine phosphorylation of SHPS-1 and its subsequent binding to SHP-2 in a C3 exoenzyme-sensitive manner in CHO cells (data not shown). Pretreatment of Rat-1 cells with cytochalasin D, which disrupts actin polymerization, inhibited LPA-induced tyrosine phosphorylation of SHPS-1 and its association with SHP-2 in a concentration-dependent manner (Figure 2c ), suggesting that these eects of LPA also require cytoskeletal reorganization.
Roles of protein kinase C (PKC) in LPA-induced tyrosine phosphorylation of SHPS-1 LPA induces polyphosphoinositide breakdown and consequent stimulation of PKC and release of Ca 2+ from intracellular stores (Hordijk et al., 1994; Moolenaar, 1994) . We therefore examined the possible role of PKC in LPA-induced tyrosine phosphorylation of SHPS-1. Prolonged treatment of cells with the PKC activator 12-O-tetradecanoyl phorbol 13-acetate (TPA) induces down-regulation of PKC activity (Nishizuka, 1986) . Exposure of Rat-1 cells to 200 nM TPA for 5 min induced tyrosine phosphorylation of SHPS-1 and interaction with SHP-2 ( Figure 3 ). TPA stimulates MAP kinase activation by a RAS-independent pathway (Ahn et al., 1992) , and pretreatment of Rat-1 cells with 800 nM TPA for 24 h markedly inhibited MAP kinase association as well as the tyrosine phosphorylation of SHPS-1 and its association with SHP-2 in response to subsequent exposure to 200 nM TPA ( Figure 3 ). Thus, prolonged pretreatment of Rat-1 cells with TPA appeared to down-regulate PKC activity. However, such TPA pretreatment did not aect LPA-induced tyrosine phosphorylation of SHPS-1 or formation of the SHPS-1-SHP-2 complex ( Figure  3 ). In addition, pretreatment of Rat-1 cells for 1 h with 3 mM GF109203X, a speci®c inhibitor for PKC, had no substantial eect on LPA-induced tyrosine phosphorylation of SHPS-1 (data not shown). Treatment of Rat-1 cells with either 100 nM wortmannin, a speci®c inhibitor for polyphosphoinositide (PI)-3 kinas (Yano et al., 1993) LPA induces the tyrosine phosphorylation of FAK, formation of actin-stress ®bers and assembly of focal contacts, apparently through a RHO-dependent pathway (Moolenaar, 1994; Ridley and Hall, 1992; Rankin et al., 1994; Sueerlein and Rozengurt, 1994; Nobes and Hall, 1995) . Given that LPA-induced tyrosine phosphorylation of SHPS-1 was sensitive to botulinus C3 exoenzyme, we examined whether FAK is responsible for this eect of LPA. For this purpose, we used cells derived from Fak knockout mice (Ilic et al., 1995) . Because antibodies that immunoprecipitate mouse SHPS-1 bound to SHP-2 were not available, we determined the extent of tyrosine phosphorylation of SHPS-1 in FAK-de®cient mouse cells by immunoprecipitation with antibodies to SHP-2 (Figure 4a ). LPA induced tyrosine phosphorylation of 120 kDa protein, which presumably was SHPS-1 and bound to SHP-2, in wild-type FAK(+/+) cells (Figure 4a , left panel). In contrast, the extent of tyrosine phosphorylation of 120 kDa SHPS-1 protein was markedly reduced in unstimulated FAK(7/7) cells, compared with that in unstimulated FAK(+/+) cells. In addition, LPA induced little increase of this parameter in FAK(7/7) cells, whereas it did *twofold increase in FAK(+/+) cells (Figure 4a , right panel). LPA has been shown to induce polyphosphoinositide breakdown (van Corven et al., 1989; Moolenaar, 1994 , n=3) . This indicates that other LPA-induced signal cascades may be intact in FAK(7/7) cells. To con®rm FAK-de®cient eects on LAP-induced tyrosine phosphorylation of SHPS-1, we transiently expressed rat SHPS-1 in FAK(+/+) and FAK(7/7) cells ( Figure  4b ). LPA induced an increase in the tyrosine phosphorylation of SHPS-1, which was exogenously expressed and immunoprecipitated with mAb 2F34 speci®c to rat SHPS-1, in FAK(+/+) cells, whereas basal and LPAinduced tyrosine phosphorylation was markedly decreased in FAK(7/7) cells. These data suggest that FAK may be essential for both basal and LPA-induced tyrosine phosphorylation of SHPS-1.
SRC kinase participates in the LPA signaling pathway that leads to activation of MAP kinase (Dikic et al., 1996; Luttrell et al., 1996) . Furthermore, the interaction of FAK with SRC results in increases in the catalytic activities of both tyrosine kinases, leading to formation of a FAK-GRB2-SOS complex that mediates MAP kinase activation (Schlaepfer et al., 1994; Schlaepfer and Hunter, 1996) . Because SHPS-1 is a substrate for v-SRC kinase Fujioka et al., 1996) , we next examined whether SRC kinase is important in LPAinduced tyrosine phosphorylation of SHPS-1. For this purpose, we generated CHO cells (CSK-WT) that overexpress rat CSK, a SRC-like kinase that inhibits the activity of SRC family kinases by phosphorylating a COOH-terminal tyrosine residue Okada et al., 1991) . Immunoblot analysis of cell lysates with antibodies to CSK revealed that the total amount of CSK in CSK-WT cells was *15 times that in the parental CHO cells (Figure 4c , left upper panel). Overexpression of CSK slightly reduced the extent of tyrosine phosphorylation of SHPS-1 in unstimulated cells and markedly reduced this parameter in response to LPA (Figure 4c, right panel) . LPA induced only *1.3-fold increase of this parameter in parental CHO cells, whereas it did *2.3-fold increase in CHO cells overexpressing Csk (Figure 4c, left bottom panel) . These results suggest that SRC or some other SRC family kinase may contribute to LPA-induced tyrosine phosphorylation of SHPS-1 and its association with SHP-2.
Eect of LPA on MAP kinase activation in cells that overexpress a catalytically inactive SHP-2 or a wild-type SHPS-1
The expression of a catalytically inactive SHP-2 inhibited MAP kinase activation by insulin (Noguchi , 1994; Milarski and Saltiel, 1994; Xiao et al., 1994; Yamauchi et al., 1995) or EGF (Bennett et al., 1996) , indicating that SHP-2 may mediate this response. To investigate the physiological consequences of SHPS-1-SHP-2 complex formation in response to LPA, we examined the eects of overexpression of a catalytically inactive SHP-2 or of SHPS-1 on LPA-induced MAP kinase activation in CHO cells. Exposure of parental CHO cells to 1 nM LPA resulted in detectable activation of MAP kinase; the maximal response was apparent at 1 mM LPA (Figure 5a ). The extent of MAP kinase activation was markedly reduced at lower concentrations (1 ± 10 nM) of LPA in CHO-SHP-2-C/S cells, which overexpress a catalytically inactive SHP-2 (Noguchi et al., 1994) ; however, the maximal response was similar to that observed in control CHO cells (Figure 5a ). The overexpression of wild-type SHPS-1 did signi®cantly enhance MAP kinase activation in response to lower concentrations of LPA in CHO-SHPS-1-WT cells, compared with that in control cells (Figure 5a ). In contrast, overexpression of a mutant SHPS-1, in which all four intracellular tyrosine residues were mutated to phenylalanine and which could not bind to SHP-2 in response to LPA (data not shown), showed no substantial eect on LPA-induced MAP kinase activation in CHO-SHPS-1-4F cells (Figure 5a ). These results are also reproduced when other cell lines, each of which overexpressed exogenous SHP-2, wild-type SHPS-1 or SHPS-4F mutant, were used for measurement of LPA-induced MAP kinase activation (data not shown). Since LPA-induced tyrosine phosphorylation was inhibited by C3 exoenzyme, we next examined the eect of C3 exoenzyme on LPA-induced MAP kinase activation (Figure 5b ). C3 exoenzyme signi®cantly reduced MAP kinase activation in response to a low concentration (10 nM) of LPA in CHO cells, whereas it did not aect the maximal response by 1 mM LPA (Figure 5b ).
Discussion
We have shown that LPA rapidly induced tyrosine phosphorylation of SHPS-1 and the formation of a complex between SHPS-1 and SHP-2 in a manner sensitive to botulinus C3 exoenzyme but resistant to PTX. LPA has been shown to increase the extent of tyrosine phosphorylation of several proteins including FAK and paxillin (Hordijk et al., 1994; Rankin et al., 1994; Sueerlein and Rozengurt, 1994) . These eects of LPA is blocked by treatment of cells with C3 exoenzyme (Rankin et al., 1994) , which speci®cally inactivates the small GTP-binding protein RHO (Ridley and Hall, 1992; Narumiya and Morii, 1993; Rankin et al., 1994; Kumagai et al., 1995) . RHO has also been implicated in the formation of actin stress ®bers and the assembly of focal contacts in response to LPA (Ridley and Hall, 1992; Nobes and Hall, 1995) , although it is not known how LPA activates RHO. Therefore, our results suggest that tyrosine phosphorylation of SHPS-1 is induced by LPA presumably through a RHO-dependent pathway. Stimulation of a PTX-insensitive G protein, presumably G q , by LPA results in polyphosphoinoside hydrolysis and the consequent production of both diacylglycerol, an activator of PKC, and inositol triphosphate (Hordijk et al., 1994; Moolenaar, 1994) . In the present study, TPA increased the extent of tyrosine phosphorylation of SHPS-1, suggesting that activation of an isoform of PKC might stimulate the tyrosine phosphorylation of SHPS-1. However, down-regulation of PKC by LPA-induced interaction of SHP-2 with SHPS-1 H Takeda et al prolonged exposure to TPA or PKC inhibition by GF109203X did not aect LPA-induced tyrosine phosphorylation of SHPS-1. Thus, PKC isoforms that are sensitive to TPA-induced down regulation and inhibition by GF109203X appear not to be responsible for LPA-induced tyrosine phosphorylation of SHPS-1. An isoform of PI-3 kinase, PI-3 kinase g, functions downstream of G protein-coupled receptors (LopezIlasaca, 1997). However, wortmannin, an inhibitor of PI-3 kinase (Yano et al., 1993) , did not aect LPAinduced tyrosine phosphorylation of SHPS-1. A serine/ threonine kinase, RHO kinase, was recently shown to play an important role in LPA-induced formation of actin stress ®bers and the assembly of focal contacts . However, LPA-induced tyrosine phosphorylation of SHPS-1 was not blocked by staurosporine, which inhibits the activity of RHO kinase . Thus, neither PI-3 kinase g nor RHO kinase appears to participate in tyrosine phosphorylation of SHPS-1 in response to LPA.
LPA-induced tyrosine phosphorylation of SHPS-1 was markedly impaired in FAK-de®cient cells. FAK is a nonreceptor tyrosine kinase that localizes with integrins at focal adhesion contacts of cells (Schaller and Parsons, 1993; Hanks and Polte, 1997) . The autophosphorylation of FAK appears to be increased by interaction of integrins with components of the extracellular matrix such as ®bronectin. Because integrins lack catalytic activity, activation of FAK is thought to play an important role in integrin-mediated signal transduction. Integrin-induced autophosphorylation of FAK results in interaction of FAK with SRC kinase mediated by the SH2 domain of SRC and phosphorylated Tyr 397 of FAK (Schlaepfer et al., 1994; Schlaepfer and Hunter, 1996) . This association of FAK with SRC promotes tyrosine phosphorylation of the kinase domain of FAK, possibly enhancing its catalytic activity (Calalb et al., 1995) . Given that LPA stimulates tyrosine phosphorylation of FAK (Hordijk et al., 1994; Rankin et al., 1994; Sueerlein and Rozengurt, 1994) , interaction of FAK and SRC might also occur in response to LPA. LPA-induced tyrosine phosphorylation of FAK, like that of SHPS-1, is sensitive to botulinus C3 exoenzyme (Rankin et al., 1994) . Together, these observations suggest that LPA may stimulate the catalytic activity of FAK, which then directly or indirectly mediates the tyrosine phosphorylation of SHPS-1. The basal level of phosphorylation of SHPS-1 was also reduced in FAK-de®cient cells as compared to wild-type cells. The apparent tyrosine phosphorylation of SHPS-1 in unstimulated cells may re¯ect the eect of cell adhesion as we have previously shown . Thus, FAK may be required for cell adhesion-induced tyrosine phosphorylation of SHPS-1. Given that CSK inhibits the activity of SRC family kinases by phosphorylating a COOH-terminal tyrosine residue in these enzymes Okada et al., 1991) , our results also suggest that a SRC family kinase may contribute to both basal and LPA-induced tyrosine phosphorylation of SHPS-1. Indeed, LPA-induced tyrosine phosphorylation of SHPS-1 is also reduced in SRC-de®cient cells derived from Src knockout mice (Takeda, Matozaki, Imamoto, Soriano and Kasuga, unpublished observation) . SHPS-1 serves as a good substrate for v-SRC kinase in vivo Fujioka et al., 1996) . Because LPA induces activation of SRC kinase (Ilic et al., 1995) , this enzyme may catalyze the tyrosine phosphorylation of SHPS-1 in response to LPA. Alternatively, the importance of SRC kinase may lie in its enhancement of the catalytic activity of FAK, as mentioned above. SHP-2 has been suggested to mediate activation of RAS ± MAP kinase cascade in response to various growth factors, including insulin, EGF, platelet-derived growth factor, and ®broblast growth factor Neel and Tonks, 1997) . Thus, the observation that LPA induces tyrosine phosphorylation of SHPS-1 and its association with SHP-2 prompted us to examine the possible role of formation of the SHPS-1-SHP-2 complex in LPA-induced activation of RAS ± MAP kinase cascade. Overexpression of a catalytically inactive SHP-2 markedly inhibited MAP kinase activation in response to low concentrations of LPA. The release of bg subunit from PTX-sensitive G i protein coupled to LPA receptors has been suggested to be an important step in LPA-induced activation of MAP kinase (Koch et al., 1994) . LPA also induces accumulation of the GTP-bound form of RAS (Hordijk et al., 1994; Moolenaar, 1994) . In addition, SRC kinase and the tyrosine kinase PYK2 have been proposed to act between G i and RAS ± MAP kinase by mediating the tyrosine phosphorylation of SHC and its subsequent association with the GRB2 adapter protein, which directs the GDP ± GTP exchanger SOS to RAS (Dikic et al., 1996; Luttrell et al., 1996) . However, Kranenburg et al. (1997) recently showed that neither SHC nor SRC is required for LPA-induced MAP kinase activation in Rat-1 ®broblasts. Our data indicate that SHP-2 may mediate LPA-induced MAP kinase activation in addition to receptor tyrosine kinase-stimulated RAS ± MAP kinase activation. The expression of a catalytically inactive SHP-2 also inhibits early gene transcription and DNA synthesis in response to thrombin, acting at a G protein-coupled receptor (Rivard et al., 1995) . Overexpression of a wild-type SHPS-1 did signi®cantly enhance MAP kinase activation in response to low concentrations of LPA and it increased the association of SHPS-1 with SHP-2 (data not shown). In contrast, overexpression of a mutant SHP-1-4F, which could not bind to SHP-2 in response to LPA, showed no substantial eect on LPAinduced MAP kinase activation, suggesting that increased formation of SHPS-1-SHP-2 complex may contribute to the enhancement of LPA-induced MAP kinase activation in CHO-SHPS-1-WT cells. Therefore, it is possible that SHPS-1 plays an important role in recruitment of SHP-2 from the cytosol to a site near the plasma membrane in response to LPA stimulation. SHP-2 may subsequently dephosphorylate and dissociate from SHPS-1 and then activate an unknown factor located at or near the plasma membrane by also catalyzing its tyrosine dephosphorylation, resulting in activation of the RAS ± MAP kinase cascade. C3 exoenzyme treatment of cells, which blocked the LPA-induced tyrosine phosphorylation of SHPS-1, signi®cantly inhibited MAP kinase activation in response to a low concentration of LPA. This also supports the possibility that tyrosine phosphorylation of SHPS-1 may be important for MAP kinase activation in response to lower concentrations of LPA, although C3 exoenzyme may aect other factors, rather than tyrosine phosphorylation of SHPS-1, related to LPA-induced MAP kinase activation.
Overexpression of a catalytically inactive SHP-2 did not aect maximal MAP kinase activation in response to high concentrations of LPA (4100 nM), whereas it markedly inhibited MAP kinase activation by high concentrations of insulin (100 nM) in the same cell line (Noguchi et al., 1994) . The overexpression of wild-type SHPS-1 did not enhance MAP kinase activation in response to high concentrations of LPA. Furthermore, C3 exoenzyme did not signi®cantly aect maximal MAP kinase activation, while it did completely block the tyrosine phosphorylation of SHPS-1. Thus, SHP-2 or formation of the SHPS-1-SHP-2 complex may not be essential for MAP kinase activation in response to high concentrations of LPA, suggesting that the mechanism of MAP kinase activation induced by high concentrations of LPA may dier from that operative at lower concentrations.
In summary, LPA stimulates tyrosine phosphorylation of SHPS-1 and its association with SHP-2, apparently in a RHO-dependent manner. These effects may require FAK and a SRC family kinase. SHP-2 complexed with tyrosine-phosphorylated SHPS-1 may mediate MAP kinase activation in response to low concentrations of LPA. However, further investigation is necessary to clarify the mechanism by which SHP-2 mediates LPA-induced activation of the RAS ± MAP kinase cascade.
Materials and methods

Cells and antibodies
Rat-1 ®broblasts were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% FBS. CHO cells overexpressing human insulin receptors (CHO-IR cells) were maintained in Ham's F-12 medium supplemented with 10% fetal bovine serum (FBS). CHO-IR cells that overexpress either a catalytically inactive SHP-2 (CHO-SHP-2-C/S) or wild-type SHPS-1 (CHO-SHPS-1-WT) were generated as previously described (Noguchi et al., 1994; Fujioka et al., 1996) .
CHO-IR cells that overexpress a mutant SHPS-1 in which all four tyrosine residues in the cytoplasmic domain are replaced by phenylalanine (CHO-SHPS-1-4F) were generated as described (Noguchi et al., 1994) . Brie¯y, point mutations that changed tyrosine residues at positions 408, 432, 449 and 473 to phenylalanine were introduced into the SHPS-1 cDNA by site-directed mutagenesis, and the mutant cDNA was cloned into the EcoRI site of the mammalian expression vector pSRa. CHO-IR cells (*5610 5 per 10 cm dish) were transfected with both 10 mg of pSRa containing the mutant SHPS-1 cDNA and 1 mg of pHyg, which contains the hygromycin B phosphotransferase gene, with the use of Lipofectamine (Gibco BRL). The cells were cultured in Ham's F-12 medium containing hygromycin B (200 mg/ml) (Wako, Osaka, Japan) and 10% FBS, and colonies were isolated 14 ± 21 days after transfection. Several cell lines expressing the mutant SHPS-1 protein were identi®ed by immunoblot analysis of cell lysates with polyclonal antibodies LPA-induced interaction of SHP-2 with SHPS-1 H Takeda et al to SHPS-1 as described below. The mutant SHPS-1-4F protein neither underwent tyrosine phosphorylation nor bound to SHP-2 in response to insulin (Takada, Matozaki and Kasuga, in preparation) .
CHO-IR cells that overexpress wild-type CSK (CSK-WT) were generated by transfection with a pSRa vector containing a rat full-length of CSK cDNA (kindly provided by Dr M Okada) as described above. FAK-de®cient mouse (FAK(7/7)) cells were established by introduction of a p53 mutation into FAK-de®cient mouse embryos as described previously (Ilic et al., 1995) . Both wild-type (FAK(+/+)) and FAK(7/7) cells were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% FBS. Semi con¯uent FAK(+/+) and FAK(7/7) cells were transiently transfected with 10 mg of pSRa containing the wild-type rat SHPS-1 cDNA with the use of Lipofectamine (Gibco) as described previously . Cells were harvested 2 days after transfection and lysed as described below for immunoprecipitation with mAb 2F34 to rat SHPS-1.
To generate a mAb speci®c to rat SHPS-1, we ®rst partially puri®ed SHPS-1 from 100 10 cm plates of con¯uent SR-3Y1 cells as described previously . The resulting SHPS-1 preparation was injected into the hind foot pads of two BALB/c mice. After three injections at 1 week intervals, lymphocytes were isolated from the draining lymph nodes and fused with P3U1 myeloma cells as described previously . Antibodies in culture supernatants of the resulting hybridomas were screened by immunoprecipitation with a membrane fraction of SR-3Y1 cells followed by immunoblot analysis with antibodies to phosphotyrosine. Positive hybridomas were rescreened by the same procedure. From several positive clones, clone 2F34 was chosen and mAb 2F34 was subsequently puri®ed from ascites¯uid of mice with a MAPS II kit (Bio-Rad). This mAb reacts well with rat SHPS-1 but shows little cross-reactivity with the corresponding protein of other species, such as hamster or mouse (Fujioka, Matozaki, Tsuda and Kasuga, unpublished data) . The mAb 4C6, which we generated previously , reacts well with hamster SHPS-1 but poorly with the corresponding protein of rat or mouse. Rabbit polyclonal antibodies to SHPS-1 or to SHP-2 (Noguchi et al., 1994) were generated to a glutathione S-transferase fusion proteins containing the COOH-terminal region of either SHPS-1 or SHP-2 as described previously. Antibodies that react speci®cally with the tyrosine-phosphorylated form of MAP kinase were obtained from New England BioLabs. Rabbit polyclonal antibodies (a91) to both p44 and p42 MAP kinase were prepared with a synthetic peptide corresponding to residues 307 ± 327 of rat MAP kinase. Horseradish peroxidase (HRP)-conjugated PY-20 mAb to phosphotyrosine as well as polyclonal antibodies to CSK were obtained from Santa Cruz Biotechnology.
Treatment of cells with bacterial toxins
Recombinant botulinus C3 exoenzyme was prepared as described previously (Rankin et al., 1994; Kumagai et al., 1995) . Rat-1 ®broblasts were incubated with or without C3 exoenzyme (7.5 mg/ml) for 48 h, washed twice with culture medium, and then incubated in the presence or absence of C3 exoenzyme (15 mg/ml) for 16 h. Rat-1 ®broblasts were incubated with PTX (100 ng/ml) (Sigma) for 24 h as previously described (Hordijk et al., 1994) .
Measurement of 1,4,5-IP3
Measurement of 1,4,5-IP3 was performed essentially as described (Matozaki and Williams, 1989 ) by using Amersham IP3 assay system (Amersham).
Immunoprecipitation and immunoblot analysis
Subcon¯uent (*70%) Rat-1 cells or CHO-IR cells (10 cm plates) were deprived of serum for 16 h, stimulated with LPA (Sigma) for various times, washed with PBS, and immediately frozen in liquid nitrogen. The cells were then lysed on ice in 1 ml of ice-cold lysis buer (20 mM Tris-HCl (pH 7.6), 140 mM NaCl, 2.6 mM CaCl 2 , 1 mM MgCl 2 , 1% (v/v) Nonidet P-40, 10% (v/v) glycerol) containing 1 mM phenylmethylsulfonyl¯uoride and 1 mM sodium vanadate. The lysates were centrifuged at 10 000 g for 15 min at 48C and the resulting supernatants were subjected to immunoprecipitated and immunoblot analysis. Brie¯y, supernatants were incubated for 4 h at 48C with various antibodies bound to protein G-Sepharose beads (2 mg of antibody on 20 ml of beads) (Pharmacia), after which the beads were washed twice with 1 ml of WG buer (50 mM HEPES-NaOH (pH 7.6), 150 mM NaCl, 0.1% (v/v) Triton X-100) and resuspended in SDS sample buer. Gel electrophoresis and immunoblot analysis, with PY-20 or other antibodies and an ECL detection kit (Amersham), were performed as described previously (Noguchi et al., 1994 Fujioka et al., 1996) .
